COLTENE Holding AG (LON:0QP7)
51.92
-0.88 (-1.66%)
Dec 15, 2025, 5:10 PM BST
COLTENE Holding AG Revenue
COLTENE Holding AG had revenue of 118.05M CHF in the half year ending June 30, 2025, a decrease of -10.18%. This brings the company's revenue in the last twelve months to 240.71M, up 0.80% year-over-year. In the year 2024, COLTENE Holding AG had annual revenue of 250.16M with 3.06% growth.
Revenue (ttm)
240.71M CHF
Revenue Growth
+0.80%
P/S Ratio
1.34
Revenue / Employee
192.41K CHF
Employees
1,251
Market Cap
295.74M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 250.16M | 7.43M | 3.06% |
| Dec 31, 2023 | 242.73M | -24.40M | -9.13% |
| Dec 31, 2022 | 267.13M | -12.12M | -4.34% |
| Dec 31, 2021 | 279.24M | 30.89M | 12.44% |
| Dec 31, 2020 | 248.35M | -25.48M | -9.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |